Absorbable Fibrin Sealant Patch Market Research, 2033
The global absorbable fibrin sealant patch market size was valued at $0.3 billion in 2023, and is projected to reach $0.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033. The major factors driving the market growth include the increasing number of surgical procedures requiring effective hemostasis, advancements in surgical techniques promoting the use of sealant patches and a growing emphasis on minimally invasive surgeries which enhance patient recovery times.
Market Introduction and Definition
An absorbable fibrin sealant patch is a medical device used to control bleeding and promote tissue healing during surgical procedures. It consists of a biodegradable patch that contains fibrinogen and thrombin, which are key components of the body's natural blood clotting mechanism. When the patch is applied to a bleeding site, the fibrinogen and thrombin interact to form a stable fibrin clot, effectively sealing the wound and reducing blood loss. The patch is designed to be absorbed by the body over time, eliminating the need for removal and minimizing the risk of foreign body reactions. This type of sealant is particularly useful in surgeries where conventional suturing or stapling is challenging or insufficient for hemostasis.
Key Takeaways
The absorbable fibrin sealant patch market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major absorbable fibrin sealant patch industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The absorbable fibrin sealant patch market growth is driven by rise in the number of surgical procedures globally, rise in geriatric population, and technological advancements in the development of sealant patches. In recent years, there has been a notable escalation in the demand for various surgical interventions across diverse medical specialties, including general surgery, orthopedics, cardiovascular surgery, and neurosurgery, among others. In addition, rise in geriatric population led to rise in the prevalence of chronic diseases such as cardiovascular diseases, cancers, and other conditions requiring surgical intervention rises. With more surgeries being performed, it led to a rise in the need for effective hemostatic agents to manage intraoperative bleeding thereby drives growth during the absorbable fibrin sealant patch market forecast period. The absorbable fibrin sealant patch addresses this need by providing a reliable method to control bleeding, which is crucial for improving patient outcomes and reducing surgery-related complications.
However, the absorbable fibrin sealant patch market might face a significant challenge due to the high cost of fibrin sealants. The substantial expenses associated with the production and utilization of fibrin sealants contribute to limited accessibility, particularly in healthcare facilities with constrained budgets. The intricate manufacturing processes and specialized components involved in fibrin sealant production contribute to elevated production costs, translating into higher prices for end-users. This financial burden may impede market growth and hinder the potential benefits of fibrin sealants in various medical applications.
Moreover, technological advancement in the absorbable fibrin sealant patch is expected to present significant absorbable fibrin sealant patch market opportunity. Technological advancements in absorbable fibrin sealant patches led to the introduction of a new generation of patches that address the limitations of liquid fibrin sealants. Patches, such as TachoSil (Corza Medical) and Evarrest (Johnson and Johnson) , are made of equine or human collagen and are associated with significant efficacy, elimination of liquid preparation complexities, and increased usability. Thus, the technological advancement in the absorbable fibrin sealant patch is expected to present significant opportunity for growth in the absorbable fibrin sealant patch market.
Parent Market Overview
The fibrin sealant market is a parent market for the absorbable fibrin sealant patch market. According to Allied Market Research, the global fibrin sealant market size was valued at $0.5 billion in 2022 and is projected to reach $1.1 billion by 2032. This growth is driven by increasing surgical procedures, advancements in medical technologies, and a growing preference for minimally invasive surgeries. Fibrin sealants, which include absorbable fibrin sealant patches, are crucial in achieving effective hemostasis during surgeries, reducing the need for transfusions, and enhancing patient recovery.
Absorbable fibrin sealant patches, a segment within the broader fibrin sealant market, benefit from these market dynamics. They are increasingly adopted for their ease of use, effectiveness in controlling bleeding, and ability to integrate into various surgical procedures, including those in cardiovascular, oncology, and neurology fields. As the parent market expands, driven by technological innovations and rising healthcare demands, the absorbable fibrin sealant patch market is projected to experience significant growth, reflecting the overall upward trend in the fibrin sealant sector.
Market Segmentation
The absorbable fibrin sealant patch market size is segmented into application, end user, and region. On the basis of the application, the market is segmented into general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgeries, ophthalmic surgeries, and others. On the basis of the end user, the market is divided into hospitals, ambulatory surgical centers, and others.? By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America maintains its leadership position in the absorbable fibrin sealant patch market share, driven by a well-established healthcare system, high adoption rates of advanced surgical technologies, and a significant number of surgical procedures performed annually. The U.S., in particular, is a key market due to its high healthcare expenditure, favorable reimbursement policies, and ongoing technological innovations. Asia-Pacific is anticipated to experience the fastest growth rate, driven by the rapidly expanding healthcare sector, increasing investments in healthcare infrastructure, and a growing patient population. Countries including China, Japan, and India are at the forefront of this growth, with rising surgical procedures and improving access to advanced medical technologies. The increasing prevalence of chronic diseases and a large aging population further drive demand for absorbable fibrin sealant in this region.
Industry Trends
According to the National Center for Health Statistics, 7.4% of adults in New York State reported they had a heart attack, angina/coronary heart disease, or stroke in 2021. This led to an increase in the number of cardiac surgeries and the use of fibrin sealants.
In 2019, the U.S. Food and Drug Administration approved an additional indication for Ethicon's EVARREST Fibrin Sealant Patch, as an adjunct to hemostasis for control of bleeding during adult liver surgery. EVARREST is a novel convergence of biologics and medical device that rapidly and reliably stops problematic bleeding during surgery on the first attempt in indicated patients. This approval highlights the patch's effectiveness in controlling bleeding during adult liver surgery which supports the market growth.
Competitive Landscape
The major players operating in the absorbable fibrin sealant patch market include Johnson & Johnso, Baxter International Inc, Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Corza Medical, LifeBond Ltd, Surgical Specialties Corporation, Biegler GmbH, Cohera Medical Inc, and Integra LifeSciences Corporation.
Recent Key Strategies and Development in Absorbable Fibrin Sealant Patch Industry
In April 2023, Corza Medical announced that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company to acquire the TachoSil manufacturing operations in Linz, Austria.
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the absorbable fibrin sealant patch market analysis from 2024 to 2033 to identify the prevailing absorbable fibrin sealant patch market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the absorbable fibrin sealant patch market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global absorbable fibrin sealant patch market trends, key players, market segments, application areas, and market growth strategies.
Absorbable Fibrin Sealant Patch Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 0.7 Billion |
 Growth Rate | CAGR of 7.8% |
 Forecast period | 2024 - 2033 |
 Report Pages | 228 |
 By Application |
|
 By End User |
|
 By Region |
|
The total market value of absorbable fibrin sealant patch market is $0.3 billion in 2023.
The market value of absorbable fibrin sealant patch market in 2033 is $0.7 billion.
The forecast period for absorbable fibrin sealant patch market is 2024 to 2033.
North America accounted for largest market share in 2023 owing to advanced healthcare infrastructure, rise in prevalence of surgical procedures, significant investments in medical technologies, and a strong focus on reducing postoperative complications through advanced hemostatic solutions.
The upcoming trends in the absorbable fibrin sealant patch market include the development of next-generation bioengineered sealants with enhanced biocompatibility and efficacy, increased adoption of these patches in minimally invasive and robotic-assisted surgeries, and expanding applications in diverse surgical fields such as orthopedics, cardiovascular, and neurosurgery.
Key driving factors include increasing surgical procedures globally, advancements in surgical techniques favoring minimally invasive approaches, and the demand for effective hemostatic solutions to reduce bleeding complications.
An absorbable fibrin sealant patch is a medical device used in surgery to promote hemostasis and seal tissues. It consists of biocompatible materials that dissolve over time.
Loading Table Of Content...
